LIFEMD INC - LFMD 8 7/8 PERP (LFMDP) Stock Fundamental Analysis
NASDAQ:LFMDP - Nasdaq - US53216B2034 - Currency: USD
Taking everything into account, LFMDP scores 4 out of 10 in our fundamental rating. LFMDP was compared to 36 industry peers in the Health Care Technology industry. Both the profitability and financial health of LFMDP have multiple concerns. LFMDP shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
LFMDP had negative earnings in the past year.
LFMDP had a positive operating cash flow in the past year.
LFMDP had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: LFMDP reported negative operating cash flow in multiple years.
1.2 Ratios
LFMDP has a Return On Assets (-18.79%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -18.79% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
LFMDP's Gross Margin of 87.99% is amongst the best of the industry. LFMDP outperforms 91.67% of its industry peers.
In the last couple of years the Gross Margin of LFMDP has grown nicely.
The Profit Margin and Operating Margin are not available for LFMDP so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 87.99% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
2. Health
2.1 Basic Checks
LFMDP does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LFMDP has more shares outstanding
Compared to 5 years ago, LFMDP has more shares outstanding
LFMDP has a better debt/assets ratio than last year.
2.2 Solvency
LFMDP has an Altman-Z score of 6.59. This indicates that LFMDP is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.59, LFMDP belongs to the top of the industry, outperforming 86.11% of the companies in the same industry.
LFMDP has a debt to FCF ratio of 5.81. This is a neutral value as LFMDP would need 5.81 years to pay back of all of its debts.
The Debt to FCF ratio of LFMDP (5.81) is better than 63.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 5.81 | ||
| Altman-Z | 6.59 |
ROIC/WACCN/A
WACC10.69%
2.3 Liquidity
LFMDP has a Current Ratio of 0.82. This is a bad value and indicates that LFMDP is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.82, LFMDP is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
LFMDP has a Quick Ratio of 0.82. This is a bad value and indicates that LFMDP is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.77, LFMDP is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.77 |
3. Growth
3.1 Past
LFMDP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.05%, which is quite impressive.
LFMDP shows a strong growth in Revenue. In the last year, the Revenue has grown by 43.07%.
Measured over the past years, LFMDP shows a very strong growth in Revenue. The Revenue has been growing by 76.23% on average per year.
EPS 1Y (TTM)54.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%105.26%
Revenue 1Y (TTM)43.07%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%48.83%
3.2 Future
The Earnings Per Share is expected to grow by 41.78% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 26.03% on average over the next years. This is a very strong growth
EPS Next Y103.4%
EPS Next 2Y61.53%
EPS Next 3Y41.78%
EPS Next 5YN/A
Revenue Next Year31.46%
Revenue Next 2Y24.57%
Revenue Next 3Y26.03%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
LFMDP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 72.35, the valuation of LFMDP can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as LFMDP.
When comparing the Price/Forward Earnings ratio of LFMDP to the average of the S&P500 Index (36.44), we can say LFMDP is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 72.35 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as LFMDP.
The rest of the industry has a similar Price/Free Cash Flow ratio as LFMDP.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 341.25 | ||
| EV/EBITDA | 400.03 |
4.3 Compensation for Growth
LFMDP's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LFMDP's earnings are expected to grow with 41.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y61.53%
EPS Next 3Y41.78%
5. Dividend
5.1 Amount
LFMDP has a Yearly Dividend Yield of 9.48%, which is a nice return.
Compared to an average industry Dividend Yield of 17.36, LFMDP pays a better dividend. On top of this LFMDP pays more dividend than 97.22% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, LFMDP pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 9.48% |
5.2 History
LFMDP has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
LFMDP has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-22.45%
EPS Next 2Y61.53%
EPS Next 3Y41.78%
23.8
+0.4 (+1.71%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners37.39%
Inst Owner ChangeN/A
Ins Owners17.86%
Ins Owner ChangeN/A
Market Cap1.08B
Analysts81.33
Price Target30.22 (26.97%)
Short Float %0.01%
Short Ratio0.95
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 9.48% |
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP-22.45%
Div Incr Years0
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)90.21%
Min EPS beat(2)61.87%
Max EPS beat(2)118.55%
EPS beat(4)2
Avg EPS beat(4)28.94%
Min EPS beat(4)-49.02%
Max EPS beat(4)118.55%
EPS beat(8)3
Avg EPS beat(8)-4.25%
EPS beat(12)5
Avg EPS beat(12)-13.27%
EPS beat(16)6
Avg EPS beat(16)-14.35%
Revenue beat(2)2
Avg Revenue beat(2)6.37%
Min Revenue beat(2)2.97%
Max Revenue beat(2)9.78%
Revenue beat(4)3
Avg Revenue beat(4)3.24%
Min Revenue beat(4)-2.71%
Max Revenue beat(4)9.78%
Revenue beat(8)6
Avg Revenue beat(8)2.84%
Revenue beat(12)7
Avg Revenue beat(12)0.03%
Revenue beat(16)7
Avg Revenue beat(16)-0.97%
PT rev (1m)23.04%
PT rev (3m)-47.06%
EPS NQ rev (1m)0%
EPS NQ rev (3m)70.52%
EPS NY rev (1m)0%
EPS NY rev (3m)132.31%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.17%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.55%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 72.35 | ||
| P/S | 4.62 | ||
| P/FCF | 341.25 | ||
| P/OCF | 70.33 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 400.03 |
EPS(TTM)-0.34
EYN/A
EPS(NY)0.33
Fwd EY1.38%
FCF(TTM)0.07
FCFY0.29%
OCF(TTM)0.34
OCFY1.42%
SpS5.15
BVpS-0.05
TBVpS-0.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -18.79% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 87.99% | ||
| FCFM | 1.35% |
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
F-Score5
Asset Turnover3.18
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 5.81 | ||
| Debt/EBITDA | 2.6 | ||
| Cap/Depr | 121.5% | ||
| Cap/Sales | 5.22% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 587.29% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.77 | ||
| Altman-Z | 6.59 |
F-Score5
WACC10.69%
ROIC/WACCN/A
Cap/Depr(3y)162.46%
Cap/Depr(5y)195.18%
Cap/Sales(3y)6.18%
Cap/Sales(5y)4.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%105.26%
EPS Next Y103.4%
EPS Next 2Y61.53%
EPS Next 3Y41.78%
EPS Next 5YN/A
Revenue 1Y (TTM)43.07%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%48.83%
Revenue Next Year31.46%
Revenue Next 2Y24.57%
Revenue Next 3Y26.03%
Revenue Next 5YN/A
EBIT growth 1Y58.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year274.77%
EBIT Next 3Y72.64%
EBIT Next 5YN/A
FCF growth 1Y112.29%
FCF growth 3YN/A
FCF growth 5Y88.7%
OCF growth 1Y188.08%
OCF growth 3YN/A
OCF growth 5Y133.93%